Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-08T05:38:12.786Z Has data issue: false hasContentIssue false

32 - Panic disorder

from Part III - Specific treatments

Published online by Cambridge University Press:  12 May 2010

Stacy Shaw Welch
Affiliation:
Anxiety and Stress Reduction Center of Seattle/Evidence Based Treatment Centers of Seattle Seattle, WA USA
Michelle Craske
Affiliation:
Department of Psychology University of California Los Angeles, CA USA
Murray B. Stein
Affiliation:
University of California San DiegoLa Jolla, CA USA
Phil Harrison-Read
Affiliation:
Department of Psychiatry Royal Free Hospital LondonUK
Peter Roy-Byrne
Affiliation:
Department of Psychiatry and Behavioural Sciences University of Washington Harborview Medical Center Seattle, WA USA
Peter Tyrer
Affiliation:
Imperial College of Science, Technology and Medicine, London
Kenneth R. Silk
Affiliation:
University of Michigan, Ann Arbor
Get access

Summary

Editor's note

Panic disorder is a relatively new diagnosis that did not exist formally before 1980, when it was first introduced into DSM-III. Its introduction divided the primary anxiety disorders into panic and generalized anxiety disorder. The assets of the diagnosis are also its handicaps. The experience of a panic attack is so profound that it cannot but be remembered starkly and clearly, and so the definition of a panic attack is remarkably easy. However, most psychiatrists never see someone having a severe panic attack, and so the reporting of symptoms is for the most part retrospective and possibly distorted by the experience. This has led to difficulty in defining panic disorder, and the official classifications of DSM and ICD differ to some extent in that ICD-10 maintains that the panic attacks in panic disorder ‘are not consistently associated with a specific symptom or object’ (as when they are symptoms forming part of a phobic disorder), whereas in DSM IV, the exclusion clause that ‘they are not better accounted for by another mental disorder’ is much more open to interpretation. Panic attacks are said to be ‘uncued’ (i.e. they come ‘out of the blue’), but increasingly, as this chapter illustrates, they are often associated with a variety of cues. It is a condition which is not so much treated, but prevented, as the successful treatments prevent the disorder (i.e. stop) the panic attacks rather than treat them.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (APA) (1994). DSM-IV Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
American Psychiatric Association (APA) (1998). Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. American Psychiatric Association. American Journal of Psychiatry, 155(5 Suppl), 1–34.
Arntz, A. & Hout, M. (1996). Psychological treatments of panic disorder without agoraphobia: cognitive therapy versus applied relaxation. Behaviour Research Therapy, 34(2), 113–21.Google Scholar
Aschenbrand, S. G., Kendall, P. C., Webb, A., Safford, S. M. & Flannery-Schroeder, E. (2003). Is childhood separation anxiety disorder a predictor of adult panic disorder and agoraphobia? A seven-year longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1478–85.Google Scholar
Bakker, A., Balkom, A. J. & Spinhoven, P. (2002). SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatrica Scandinavica, 106(3), 163–7.Google Scholar
Barlow, D. H. (1988). Anxiety and its Disorders: The Nature and Treatment of Anxiety and Panic. New York, NY: Guilford Press.
Barlow, D. H. (2002). Anxiety and its Disorders: The Nature and Treatment of Anxiety and Panic. New York, NY: Guilford Press.
Barlow, D. H., Gorman, J. M., Shear, M. K. & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. Journal of the American Medical Association, 283(19), 2529–36.Google Scholar
Barlow, J. H., Ellard, D. R., Hainsworth, J. M., Jones, F. R. & Fisher, A. (2005). A review of self-management interventions for panic disorders, phobias and obsessive-compulsive disorders. Acta Psychiatrica Scandinavica, 111(4), 272–85.Google Scholar
Barrett, P. M. L., Lock, S. & Farrell, J. (2005). Developmental differences in universal preventive intervention for child anxiety. Clinical Child Psychology and Psychiatry, 10(4), 539–55.Google Scholar
Bebbington, P. E., Brugha, T. S., Meltzer, H.et al. (2000). Neurotic disorders and the receipt of psychiatric treatment. Psychological Medicine, 30(6), 1369–76.Google Scholar
Biederman, J., Faraone, S. V., Marrs, A.et al. (1997). Panic disorder and agoraphobia in consecutively referred children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 36(2), 214–23.Google Scholar
Biederman, J., Petty, C., Faraone, S. V.et al. (2005). Parental predictors of pediatric panic disorder/agoraphobia: a controlled study in high-risk offspring. Depression and Anxiety, 22(3), 114–20.CrossRefGoogle Scholar
Bienvenu, O. J., Onyike, C. U., Stein, M. B.et al. (2006). Agoraphobia in general population adults: incidence and longitudinal relationships with panic, with clinical reappraisal. British Journal of Psychiatry, 188, 432–8.Google Scholar
Block, R. I., Ghoneim, M. M., Fowles, D. C., Kumar, V. & Pathak, D. (1987). Effects of a subanesthetic concentration of nitrous oxide on establishment, elicitation, and semantic and phonemic generalization of classically conditioned skin conductance responses. Pharmacological and Biochemical Behaviour, 28(1), 7–14.CrossRefGoogle Scholar
Bouton, M. E., Mineka, S. & Barlow, D. H. (2001). A modern learning theory perspective on the etiology of panic disorder. Psychological Review, 108(1), 4–32.Google Scholar
Bower, P. & Gilbody, S. (2005). Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. British Journal of Psychiatry, 186, 11–17.Google Scholar
Boyer, W. (1995). Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. International Clinical Psychopharmacology, 10(1), 45–9.CrossRefGoogle Scholar
Bradwejn, J., Ahokas, A., Stein, D. J., Salinas, E., Emilien, G. & Whitaker, T. (2005). Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study. British Journal of Psychiatry, 187, 352–9.CrossRefGoogle Scholar
Bruce, S. E., Vasile, R. G., Goisman, R. M.et al. (2003). Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? American Journal of Psychiatry, 160(8), 1432–8.Google Scholar
Bruce, S. E., Yonkers, K. A., Otto, M. W.et al. (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. American Journal of Psychiatry, 162(6), 1179–87.Google Scholar
Carlbring, P., Nilsson-Ihrfelt, E., Waara, J.et al. (2005). Treatment of panic disorder: live therapy vs. self-help via the Internet. Behavior Research Therapy, 43(10), 1321–33.CrossRefGoogle Scholar
Charney, D. S., Woods, S. W., Goodman, W. K.et al. (1986). Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. Journal of Clinical Psychiatry, 47(12), 580–6.Google Scholar
Clark, D. M. (1986). A cognitive approach to panic. Behaviour Research Therapy, 24(4), 461–70.Google Scholar
Clark, D. M., Salkovskis, P. M., Gelder, M. et al. (1988). Test of a cognitive theory of panic. In Panic and Phobias II: Treatments and Variables Affecting Course and Outcome, ed. Hand, I. & Wittchen, H. V., pp. 71–90. Berlin: Springer-Verlag.
Clark, D. M., Salkovskis, P. M., Hackmann, A., Wells, A., Ludgate, J. & Gelder, M. (1999). Brief cognitive therapy for panic disorder: a randomised controlled trial. Journal of Consulting and Clinical Psychology, 67, 583–9.Google Scholar
Craske, M. G. (1999). Anxiety Disorders: Psychological Approaches to Theory and Treatment. Boulder, CO: Westview Press.
Craske, M. G., Lang, A. J., Rowe, M.et al. (2002). Presleep attributions about arousal during sleep: nocturnal panic. Journal of Abnormal Psychology, 111(1), 53–62.Google Scholar
Craske, M. G., Edlund, M. J., Sullivan, G.et al. (2005). Perceived unmet need for mental health treatment and barriers to care among patients with panic disorder. Psychiatric Services, 56(8), 988–94.Google Scholar
Beurs, E., Lange, A., Dyck, R. & Koele, P. (1995). Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome. Australian and N Z Journal of Psychiatry, 29(1), 104–13.CrossRefGoogle Scholar
Gardenswarz, C. & Craske, M. (2001). Prevention of panic. Behavior Therapy, 32, 725–38.Google Scholar
Garssen, C. & Dyck, R. (1992). Breathing retraining: a rational placebo? Clinical Psychology Review, 12(2), 141–53.Google Scholar
Goddard, A. W., Brouette, T., Almai, A., Jetty, P., Woods, S. W. & Charney, D. (2001). Early coadministration of clonazepam with sertraline for panic disorder. Archives of General Psychiatry, 58(7), 681–6.Google Scholar
Goddard, A. W., Mason, G. F., Almai, A.et al. (2001). Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Archives in General Psychiatry, 58(6), 556–61.CrossRefGoogle Scholar
Goddard, A. W., Mason, G. F., Appel, M.et al. (2004). Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. American Journal of Psychiatry, 161(12), 2186–93.CrossRefGoogle Scholar
Goisman, R. M., Goldenberg, I., Vasile, R. G. & Keller, M. B. (1995). Comorbidity of anxiety disorders in a multicenter anxiety study. Comparative Psychiatry, 36(4), 303–11.CrossRefGoogle Scholar
Goodwin, R. D. & Hoven, C. W. (2002). Bipolar-panic comorbidity in the general population: prevalence and associated morbidity. Journal of Affective Disorders, 70(1), 27–33.Google Scholar
Gorman, J. M., Kent, J. M., Sullivan, G. M. & Coplan, J. D. (2000). Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry, 157(4), 493–505.CrossRefGoogle Scholar
Gould, R. A., Otto, M. & Pollack, M. (1995). A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review, 15, 819–44.CrossRefGoogle Scholar
Greenberg, P. E., Sisitsky, T., Kessler, R. C.et al. (1999). The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry, 60(7), 427–35.Google Scholar
Heldt, E. M., Gisele, G., Kipper, L., Blaya, C., Isolan, L. & Otto, M. W. (2006). One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission. Behaviour Research and Therapy, 44(5), 657–65.CrossRefGoogle Scholar
Hope, D. A., Rapee, R. M., Heimberg, R. G. & Dombeck, M. J. (1990). Representations of the self in social phobia: vulnerability to social threat. Cognitive Therapy and Research, 14(2), 177–89.CrossRefGoogle Scholar
Isensee, B., Wittchen, H. U., Stein, M. B., Hofler, M. & Lieb, R. (2003). Smoking increases the risk of panic: findings from a prospective community study. Archives in General Psychiatry, 60(7), 692–700.CrossRefGoogle Scholar
Jacob, R. G., Furman, J. M., Clark, D. B. & Durrant, J. D. (1992). Vestibular symptoms, panic, and phobia: overlap and possible relationships. Annals of Clinical Psychiatry, 4(3), 163–74.Google Scholar
Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L. & Hendriks, G.-J. (2002). A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. Journal of Clinical Psychiatry, 63(9), 772–7.CrossRefGoogle Scholar
Katon, W., Russo, J., Sherbourne, C.et al. (2006). Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychological Medicine, 36(3), 353–63.Google Scholar
Katschnig, H. & Amering, M. (1998). The long-term course of panic disorder and its predictors. Journal of Clinical Psychopharmacology, 18(6 Suppl. 2), 6S–11S.CrossRefGoogle Scholar
Kenardy, J. A., Dow, M. G., Johnston, D. W., Newman, M. G., Thomson, A. & Taylor, C. B. (2003). A comparison of delivery methods of cognitive-behavioral therapy for panic disorder: an international multicenter trial. Journal of Consulting and Clinical Psychology, 71(6), 1068–75.CrossRefGoogle Scholar
Kenardy, J. R. S. & Dob, R. (2005) Cognitive behaviour therapy for panic disorder: long-term follow-up. Cognitive Behaviour Therapy, 34(2), 75–8.CrossRefGoogle Scholar
Kenardy, J. M. K. & Rosa, V. (2006). Internet-delivered indicated prevention for anxiety disorders: six-month follow-up. Clinical Psychologist, 10(1), 39–42.CrossRefGoogle Scholar
Kendler, K. S. (2005). “A gene for” the nature of gene action in psychiatric disorders. American Journal of Psychiatry, 162(7), 1243–52.CrossRefGoogle Scholar
Kent, J. M. & Rauch, S. L. (2003). Neurocircuitry of anxiety disorders. Current Psychiatry Reports, 5(4), 266–73.CrossRefGoogle Scholar
Kent, J. M., Coplan, J. D., Mawlawi, O.et al. (2005). Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder. American Journal of Psychiatry, 162(7), 1379–81.Google Scholar
Kessler, R., Stang, P., Wittchen, H., Ustun, B., Roy-Byrne, P. & Walters, E. (1998). Lifetime panic-depression comorbidity in the national comorbidity survey. Archives of General Psychiatry, 55, 801–8.CrossRefGoogle Scholar
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R. and Walters, E. E. (2005a). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives in General Psychiatry, 62(6), 593–602.Google Scholar
Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E. (2005b). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives in General Psychiatry, 62(6), 617–27.Google Scholar
Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K. & Walters, E. E. (2006). The Epidemiology of Panic Attacks, Panic Disorder, and Agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63, 415–24.Google Scholar
Krystal, J. H., Deutsch, D. N. & Charney, D. S. (1996). The biological basis of panic disorder. Journal of Clinical Psychiatry, 57 (Suppl. 10), 23–31; discussion 32–3.Google Scholar
McNally, R. J. (2002). Anxiety sensitivity and panic disorder. Biological Psychiatry, 52(10), 938–46.CrossRefGoogle Scholar
Marks, I. M., Swinson, R. P., Basoglu, M.et al. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776–87.CrossRefGoogle Scholar
Marks, I. M., Kenwright, M., McDonough, M., Whittaker, M. & Mataix-Cols, D. (2004). Saving clinicians' time by delegating routine aspects of therapy to a computer: a randomized controlled trial in phobia/panic disorder. Psychological Medicine, 34(1), 9–17.CrossRefGoogle Scholar
Massana, G., Gasto, C., Junque, C.et al. (2002). Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with (1)H magnetic resonance spectroscopy. Neuroimage, 16(3 Pt 1), 836–42.CrossRefGoogle Scholar
Massana, G., Serra-Grabulosa, J. M., Salgado-Pineda, P.et al. (2003). Amygdala atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage, 19(1), 80–90.CrossRefGoogle Scholar
Mitte, K. (2005). A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. Journal of Affective Disorders, 88(1), 27–45.CrossRefGoogle Scholar
Neumeister, A., Bain, E., Nugent, A. C.et al. (2004). Reduced serotonin type 1 A receptor binding in panic disorder. Journal of Neuroscience, 24(3), 589–91.CrossRefGoogle Scholar
NICE (2004). Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. London: National Collaborating Centre for Primary Care. (www.nice.org.uk/CG022fullguideline)
Norton, C. R., Cox, B. J. & Malan, J. (1992). Nonclinical panickers: a critical review. Clinical Psychology Review, 12, 121–39.CrossRefGoogle Scholar
Noyes, R. Jr, Anderson, D. J., Clancy, J.et al. (1984). Diazepam and propranolol in panic disorder and agoraphobia. Archives in General Psychiatry, 41(3), 287–92.CrossRefGoogle Scholar
Otto, M. W., Tuby, K. S., Gould, R. A., McLean, R. Y. & Pollack, M. H. (2001). An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. American Journal of Psychiatry, 158(12), 1989–92.CrossRefGoogle Scholar
Pignone, M. P., Gaynes, B. N., Rushton, J. L.et al. (2002). Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Annales of Internal Medicine, 136(10), 765–76.CrossRefGoogle Scholar
Pitts, F. N. Jr. & McClure, J. N. Jr (1967). Lactate metabolism in anxiety neurosis. New England Journal of Medicine, 277(25), 1329–36.CrossRefGoogle Scholar
Pollack, M. H., Allgulander, C., Bandelow, B.et al. (2003). WCA recommendations for the long-term treatment of panic disorder. CNS Spectrums, 8(8 (Suppl. 1), 17–30.Google Scholar
Proudfoot, J., Ryden, C., Everitt, B.et al. (2004). Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. British Journal of Psychiatry, 185, 46–54.CrossRefGoogle Scholar
Reiss, S. (1980). Pavlovian conditioning and human fear: an expectancy model. Behavior Therapy, 11(3), 380–96.Google Scholar
Rickels, K., Schweizer, E., Weiss, S. & Zavodnick, S. (1993). Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. Archives of General Psychiatry, 50(1), 61–8.Google Scholar
Rollman, B. L., Belnap, B. H., Reynolds, C. F., Schulberg, H. C. & Shear, M. K. (2003). A contemporary protocol to assist primary care physicians in the treatment of panic and generalized anxiety disorders. General Hospital Psychiatry, 25, 74–82.CrossRefGoogle Scholar
Rosenbaum, J. F., Biederman, J., Hirshfeld-Becker, D. R.et al. (2000). A controlled study of behavioral inhibition in children of parents with panic disorder and depression. American Journal of Psychiatry, 157(12), 2002–10.CrossRefGoogle Scholar
Roth, M. (1984). Agoraphobia, panic disorder and generalized anxiety disorder: some implications of recent advances. Psychiatric Developments, 2(1), 31–52.Google Scholar
Roy-Byrne, P. P. & Cowley, D. S. (1995). Course and outcome in panic disorder: A review of recent follow-up studies. Anxiety, 1, 151–60.CrossRefGoogle Scholar
Roy-Byrne, P. P., & Cowley, D. (2002). Pharamcologic treatments for panic disorder, generalized anxiety disorder, specific phobia and social anxiety disorders. In A Guide to Treatments that Work, ed. Nathan, P. E. and Gorman, J., pp. 337–65. New York: Oxford University Press.
Roy-Byrne, P. P., Geraci, M. & Uhde, T. W. (1986). Life events and the onset of panic disorder. American Journal of Psychiatry, 143(11), 1424–7.CrossRefGoogle Scholar
Roy-Byrne, P. P., Stein, M. B., Russo, J.et al. (1999). Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. Journal of Clinical Psychiatry, 60(7), 492–9.CrossRefGoogle Scholar
Roy-Byrne, P. P., Katon, W., Cowley, D. S.et al. (2000). Panic disorder in primary care: Biopsychosocial differences between recognized and unrecognized patients. General Hospital Psychiatry, 22, 405–11.CrossRefGoogle Scholar
Roy-Byrne, P. P., Katon, W. J., Cowley, D. S. & Russo, J. (2001). A randomized trial of collaborative care for patients with panic disorder in primary care. Archives of General Psychiatry, 58, 869–76.Google Scholar
Roy-Byrne, P. P., Craske, M. G., Stein, M. B.et al. (2005). A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Archives of General Psychiatry, 62(3), 290–8.CrossRefGoogle Scholar
Roy-Byrne, P. P., Craske, M. G. & Stein, M. B. (2006). Panic disorder. Lancet, 368, 1023–32.Google Scholar
Sakai, Y., Kumano, H., Nishikawa, M.et al. (2005). Cerebral glucose metabolism associated with a fear network in panic disorder. Neuroreport, 16(9), 927–31.Google Scholar
Sheehan, D. V., Davidson, J., Manschreck, T. & Fleet, Wyck J. (1983). Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. Journal of Clinical Psychopharmacology, 3(1), 28–31.CrossRefGoogle Scholar
Sheehan, D. V., Raj, A. B., Harnett-Sheehan, K., Soto, S. & Knapp, E. (1993). The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study. Acta Psychiatrica Scandinavica, 88(1), 1–11.CrossRefGoogle Scholar
Sibille, E., Pavlides, C., Benke, D. & Toth, M. (2000). Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. Journal of Neuroscience, 20(8), 2758–65.Google Scholar
Smits, J. A. J. O. C., Conall, M. & Otto, M. W. (2006). Combining cognitive-behavioral therapy and pharmacotherapy for the treatment of panic disorder. Journal of Cognitive Psychotherapy, 20(1), 75–84.CrossRefGoogle Scholar
Stein, M. B., Walker, J. R., Anderson, G.et al. (1996). Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample. American Journal of Psychiatry, 153(2), 275–7.CrossRefGoogle Scholar
Stein, M. B., Norton, G. R., Walker, J. R., Chartier, M. J. & Graham, R. (2000). Do SSRIs enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study. Psychiatry Research, 94, 191–200.CrossRefGoogle Scholar
Stein, M. B., Sherbourne, C. D., Craske, M. G.et al. (2004). Quality of care for primary care patients with anxiety disorders. American Journal of Psychiatry, 161(12), 2230–7.CrossRefGoogle Scholar
Swinson, R. P., Soulios, C., Cox, B. J. & Kuch, K. (1992). Brief treatment of emergency room patients with panic attacks. American Journal of Psychiatry, 149(7), 944–6.CrossRefGoogle Scholar
Telch, M. & Lucas, R. (1994). Combined pharmacological and psychological treatment of panic disorder: current status and future directions. In Treatment of Panic/Disorder: A Consensus Development Conference. American Psychiatric Press.
Telch, M. J., Schmidt, N. B., Jaimez, T. L., Jacquin, K. M. & Harrington, P. J. (1995). Impact of cognitive-behavioral treatment on quality of life in panic disorder patients. Journal of Consulting Clinical Psychology, 63(5), 823–30.CrossRefGoogle Scholar
Trivedi, M., Fava, M., Wisniewski, S. R.et al. (2006). Augmentation after the Failure of SSRIs for Depression. New England Journal of Medicine, 354(12), 1243–52.CrossRefGoogle Scholar
Tsao, J. C. I., Mystkowski, J., Zucker, B. & Craske, M. G. (2002). Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: replication and extension. Behavior Therapy, 33, 493–509.CrossRefGoogle Scholar
Uchida, R. R., Del-Ben, C. M., Santos, A. C.et al. (2003). Decreased left temporal lobe volume of panic patients measured by magnetic resonance imaging. Brazilian Journal of Medical and Biological Research, 36(7), 925–9.CrossRefGoogle Scholar
Wang, P. S., Berglund, P. & Kessler, R. C. (2000). Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. Journal of General Internal Medicine, 15(5), 284–92.CrossRefGoogle Scholar
Watanabe, A., Nakao, K., Tokuyama, M. & Takeda, M. (2005). Prediction of first episode of panic attack among white-collar workers. Psychiatry and Clinical Neuroscience, 59(2), 119–26.CrossRefGoogle Scholar
Westen, D. & Morrison, K. (2001). A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Journal of Consulting Clinical Psychology, 69(6), 875–99.CrossRefGoogle Scholar
Wittchen, H. U., Reed, V. & Kessler, R. C. (1998). The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Archives of General Psychiatry, 55(11), 1017–24.CrossRefGoogle Scholar
Young, A. S., Klap, R., Sherbourne, C. D. & Wells, K. B. (2001). The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry, 58(1), 55–61.CrossRefGoogle Scholar
Zimmermann, P., Wittchen, H. U., Hofler, M., Pfister, H., Kessler, R. C. & Lieb, R. (2003). Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychological Medicine, 33(7), 1211–22.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Panic disorder
    • By Stacy Shaw Welch, Anxiety and Stress Reduction Center of Seattle/Evidence Based Treatment Centers of Seattle Seattle, WA USA, Michelle Craske, Department of Psychology University of California Los Angeles, CA USA, Murray B. Stein, University of California San DiegoLa Jolla, CA USA, Phil Harrison-Read, Department of Psychiatry Royal Free Hospital LondonUK, Peter Roy-Byrne, Department of Psychiatry and Behavioural Sciences University of Washington Harborview Medical Center Seattle, WA USA
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.034
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Panic disorder
    • By Stacy Shaw Welch, Anxiety and Stress Reduction Center of Seattle/Evidence Based Treatment Centers of Seattle Seattle, WA USA, Michelle Craske, Department of Psychology University of California Los Angeles, CA USA, Murray B. Stein, University of California San DiegoLa Jolla, CA USA, Phil Harrison-Read, Department of Psychiatry Royal Free Hospital LondonUK, Peter Roy-Byrne, Department of Psychiatry and Behavioural Sciences University of Washington Harborview Medical Center Seattle, WA USA
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.034
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Panic disorder
    • By Stacy Shaw Welch, Anxiety and Stress Reduction Center of Seattle/Evidence Based Treatment Centers of Seattle Seattle, WA USA, Michelle Craske, Department of Psychology University of California Los Angeles, CA USA, Murray B. Stein, University of California San DiegoLa Jolla, CA USA, Phil Harrison-Read, Department of Psychiatry Royal Free Hospital LondonUK, Peter Roy-Byrne, Department of Psychiatry and Behavioural Sciences University of Washington Harborview Medical Center Seattle, WA USA
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.034
Available formats
×